lasofoxifene topical (AZU-101) / Azure Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lasofoxifene topical (AZU-101) / Azure Biotech
NCT06197568: Open-Label Study of Vaginal AZU-101 in Postmenopausal Women

Not yet recruiting
1/2
35
NA
Lasofoxifene Tartrate (AZU-101), AZU-101
Azure Biotech Inc.
Postmenopausal Symptoms
09/24
12/24

Download Options